BioXgen Holdings, Inc.
Raising nowOperatingTucson, AZ
BioXgen Holdings is developing a cardiac patch made from porcine extracellular matrix, placed during open-heart surgery to help prevent post-operative atrial fibrillation. It plans to sell the patch to U.S. hospitals that perform cardiac surgery, and is working toward FDA 510(k) clearance.
This company has an open fundraising round.
Financials
FY2023–FY2024 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inDotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.
Cap table
Share counts as of Jan 14, 2026| Class | Outstanding | Votes / share | Share of total | Votes | Last price |
|---|---|---|---|---|---|
| Class A common stock | 30,000,000 | 1 | 50.0% | 9.09% | — |
| Class B common stock | 30,000,000 | 10 | 50.0% | 90.9% | — |
| Total | 60,000,000 | 100% | 100% |
Principal holders% as the filing states it, Apr 30, 2026
- David P. Skinner30,000,000 Class B common stock91.0%of votes
- Everyone else (not named in filings)9%
Sold to the crowd
- Reg CF · Jan 202658,644 Units of the Co-Issuer corresponding with Class C Common Stock of the Issuer at $1.43$83.9K· 52 investors
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
1 personNames and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
never closed a Reg CF raise
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.